Navigation Links
Fatty Acids Profile, Essential (C12-C22)

ProductsFatty Acids Profile, Essential (C12-C22)
Company ARUP Laboratories
Item Fatty Acids Profile, Essential (C12-C22)
Features 
Description ARUP Laboratories is a national reference laboratory and a worldwide leader in innovative laboratory research and development. ARUP offers an extensive test menu of highly complex and unique medical tests in clinical and anatomic pathology. Owned by the University of Utah, ARUP Laboratories' clients include more than half of the nation's university teaching hospitals and children's hospitals, major commercial laboratories, military and government facilities, and major clinics.
Info ARUP Laboratories
Customer Service: (800) 522-2787
Web site: http://www.aruplab.com

Related medicine products :

1. Fatty Acid, Stool
2. Fatty Acids Profile, Peroxisomal (C22-C26)
3. Fatty Acids, Free
4. Free Fatty Acids
5. 3-Hydroxy Fatty Acids
6. Very Long Chain Fatty Acids
7. Amino Acids Quantitative, CSF
8. Amino Acids Quantitative, Urine
9. Amino Acids Quantitative, Plasma
10. Bile Acids, Fractionated & Total
11. Bile Acids, Total
Breaking Medicine Technology:Daniel K. Spiegelman Elected to Board of Directors of Omeros 2TNF-Alpha Inhibitors Are Being Used More Often To Treat Newly Diagnosed Patients With Crohn's Disease 2TNF-Alpha Inhibitors Are Being Used More Often To Treat Newly Diagnosed Patients With Crohn's Disease 3Giant Eagle(R) Pharmacy Receives Award for Operational Excellence 2Slumps in Pharmaceutical Profitability Tied to Insufficient Management Training 5459 1Slumps in Pharmaceutical Profitability Tied to Insufficient Management Training 5459 2Slumps in Pharmaceutical Profitability Tied to Insufficient Management Training 5459 3ZyStor Therapeutics Inc Cleared to Begin Clinical Trial for Targeted Protein Therapeutic for the Treatment of Pompe Disease 5457 1ZyStor Therapeutics Inc Cleared to Begin Clinical Trial for Targeted Protein Therapeutic for the Treatment of Pompe Disease 5457 2ZyStor Therapeutics Inc Cleared to Begin Clinical Trial for Targeted Protein Therapeutic for the Treatment of Pompe Disease 5457 3Lilly to Sell Tippecanoe Manufacturing Site to Evonik Industries 5455 1Lilly to Sell Tippecanoe Manufacturing Site to Evonik Industries 5455 2Lilly to Sell Tippecanoe Manufacturing Site to Evonik Industries 5455 3Lilly to Sell Tippecanoe Manufacturing Site to Evonik Industries 5455 4